* eHealth Inc is expected to show a fall in quarterly revenue when it reports results on November 6 for the period ending September 30 2024

* The Austin Texas-based company is expected to report a 9.5% decrease in revenue to $58.557 million from $64.72 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on August 7 2024, for the period ended September 30, was for revenue between $67.31 million and $68.60 million. (SAL majority is on Total Revenue basis)

* ​LSEG's mean analyst estimate for eHealth Inc is for a loss of $1.28 per share.

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

* The mean earnings estimate of analysts was unchanged in the last three months. ​

* Wall Street's median 12-month price target for eHealth Inc is $5.00​, above​ its last closing price of $4.86. ​​​

The company's guidance on August 7 2024 for the period ended September 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between 67.30672 million and -29.2136 million $(USD)$. Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI

ENDING ARTESTIMAT ESTIMATE MET, SE %

E® MISSED

Jun. 30 2024 -0.86 -0.84 -1.17 Missed -39.3

Jan. 1 2024 -0.65 -0.62 -0.77 Missed -24.2

Jan. 1 0001 1.85 1.84 1.44 Missed -21.9​

Sep. 30 2023 -1.41 -1.38 -1.45 Missed -4.7

​​Jun. -1.09 -1.11 -0.96 Beat 13.2

30 2023

Mar. 31 2023 -0.94 -0.95 -0.83 Beat 12.4​

Dec. 31 2022 0.71 0.56 1.14 Beat 103

Sep. 30 2022 -1.47 -1.45 -1.17 Beat 19.2

This summary was machine generated November 4 at 15:45 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)